Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi approved by USFDA
95.7% of patients responded to Breyanzi in the TRANSCEND FL trial
95.7% of patients responded to Breyanzi in the TRANSCEND FL trial
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial
Hepatitis B infects over 40 million people in India
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
Vision loss due to Glaucoma can be prevented if it is detected and treated early
‘Unmask Anemia’ aims to simplify assessment of iron deficiency anemia risk with an easy online self-test based on common signs and symptoms
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
Subscribe To Our Newsletter & Stay Updated